During the past decade, Dandenong Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dandenong Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 4 trials, followed by "Belinda Howe" with 1 trials sponsored, "McMaster University" with 1 trials sponsored, "Medtronic Cardiovascular" with 1 trials sponsored and "Menzies School of Health Research" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dandenong Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 3 trials as a collaborator, "Australasian College for Emergency Medicine" with 1 trials as a collaborator, "Australasian Kidney Trials Network" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator and "Australian Red Cross" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Dandenong Hospital" are "Critical Illness" (3 trials), "Age of Blood" (1 trials), "Aortic Aneurysm" (1 trials), "Arterial Thrombosis" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Dandenong Hospital" in a lesser frequency.

Most popular intervention types in "Dandenong Hospital" are "Other" (6 trials), "Drug" (5 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.9% sodium chloride" (1 trials), "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials) and "Angiotensin Receptor Blockers" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dandenong Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Dandenong Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Dandenong Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dandenong Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".